The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Eli Lilly and Co

NYSE: LLY
Last

(U.S.) $72.45

Today's change0.00 0.00%
Updated December 18 4:01 PM EST. Delayed by at least 15 minutes.
 

Eli Lilly and Co

NYSE: LLY
Last

(U.S.) $72.45

Today's change0.00 0.00%
Updated December 18 4:01 PM EST. Delayed by at least 15 minutes.

Eli Lilly and Co closed at (U.S.)$72.45.

Over the last five days, shares have gained 1.17% and are currently 3.53% off of the 52-week high. Shares have outperformed the S&P 500 by 29.60% during the last year.

Key company metrics

  • Open(U.S.) $71.20
  • Previous close(U.S.) $72.45
  • High(U.S.) $72.48
  • Low(U.S.) $70.91
  • Bid / Ask-- / --
  • YTD % change+42.06%
  • Volume5,875,562
  • Average volume (10-day)5,935,689
  • Average volume (1-month)5,188,113
  • Average volume (3-month)4,589,084
  • 52-week range(U.S.) $49.13 to (U.S.) $75.10
  • Beta0.44
  • Trailing P/E29.00×
  • P/E 1 year forward26.04×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $2.00
  • Dividend yield2.76%
  • Trailing EPS(U.S.) $2.50
Updated December 18 4:01 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+13.25%

Based on its net profit margin of 13.25%, Eli Lilly and Co is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.93%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue4,8764,9364,6835,809
Total other revenue--------
Total revenue4,8764,9364,6835,809
Gross profit3,6093,7463,4604,422
Total cost of revenue1,2671,1901,2231,387
Total operating expense4,3144,0493,8484,908
Selling / general / administrative1,6721,6641,4851,954
Research & development1,2431,1951,1091,475
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)13103193
Other operating expenses, total--------
Operating income562887835901
Interest income (expense), net non-operating-48-45-46-40
Gain (loss) on sale of assets--------
Other--------
Income before tax656940891910
Income after tax501734728728
Income tax, total155207163182
Net income501734728728
Total adjustments to net income--------
Net income before extra. items501734728728
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items501734728728
Inc. avail. to common incl. extra. items501734728728
Diluted net income501734728728
Dilution adjustment--------
Diluted weighted average shares1,0741,0761,0761,079
Diluted EPS excluding extraordinary itemsvalue per share0.470.680.680.67
Dividends per sharevalue per share0.490.490.490.49
Diluted normalized EPSvalue per share0.580.680.700.75